CENTRAL TRUST Co raised its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 3,086.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 147,028 shares of the biotechnology company’s stock after buying an additional 142,414 shares during the quarter. Axon Enterprise comprises 1.1% of CENTRAL TRUST Co’s portfolio, making the stock its 24th biggest position. CENTRAL TRUST Co’s holdings in Axon Enterprise were worth $62,122,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently modified their holdings of AXON. Three Bridge Wealth Advisors LLC acquired a new position in Axon Enterprise during the third quarter valued at approximately $41,000. King Luther Capital Management Corp increased its stake in Axon Enterprise by 1,731.8% in the third quarter. King Luther Capital Management Corp now owns 116,539 shares of the biotechnology company’s stock valued at $49,240,000 after purchasing an additional 110,177 shares in the last quarter. New Mexico Educational Retirement Board increased its stake in Axon Enterprise by 5,332.1% in the third quarter. New Mexico Educational Retirement Board now owns 213,807 shares of the biotechnology company’s stock valued at $90,338,000 after purchasing an additional 209,871 shares in the last quarter. Maryland State Retirement & Pension System raised its holdings in Axon Enterprise by 6,258.0% in the third quarter. Maryland State Retirement & Pension System now owns 260,804 shares of the biotechnology company’s stock worth $110,195,000 after purchasing an additional 256,702 shares during the period. Finally, Cabot Wealth Management Inc. raised its holdings in Axon Enterprise by 11,781.7% in the third quarter. Cabot Wealth Management Inc. now owns 223,139 shares of the biotechnology company’s stock worth $94,281,000 after purchasing an additional 221,261 shares during the period. 79.08% of the stock is owned by institutional investors.
Axon Enterprise Price Performance
NASDAQ AXON opened at $315.42 on Thursday. The firm’s 50 day moving average is $426.24 and its 200-day moving average is $470.65. The company has a quick ratio of 2.60, a current ratio of 3.00 and a debt-to-equity ratio of 0.76. The company has a market capitalization of $25.68 billion, a PE ratio of 101.10, a price-to-earnings-growth ratio of 5.75 and a beta of 1.48. Axon Enterprise, Inc has a 12-month low of $291.45 and a 12-month high of $665.07.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its earnings results on Thursday, November 5th. The biotechnology company reported $1.72 EPS for the quarter, missing the consensus estimate of $1.89 by ($0.17). Axon Enterprise had a return on equity of 3.87% and a net margin of 7.56%. The business had revenue of $908.55 million for the quarter, compared to analyst estimates of $934.33 million. During the same quarter in the previous year, the company posted $1.17 EPS. The business’s revenue for the quarter was up 27.8% compared to the same quarter last year. Equities research analysts anticipate that Axon Enterprise, Inc will post 2.10 earnings per share for the current fiscal year.
Latest Axon Enterprise News
Investors following AXON have been watching these news items:
- Neutral Sentiment: Axon is investing $1.2 billion for a 37% stake in drone maker Skydio and will distribute its products to U.S. public-safety customers. The deal could broaden Axon’s offering, but its sizeable cost makes the investment a factor for investors to weigh. Axon invests $1.2B into Skydio and becomes its U.S. public safety distributor
- Negative Sentiment: Axon’s third-quarter adjusted EPS missed Wall Street expectations, and cautious guidance contributed to a sharp share decline. The company also said federal contract delays shifted $130 million of revenue out of 2026, weighing on near-term expectations. Axon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?
- Negative Sentiment: Several law firms have announced investigations into potential securities-law claims related to Axon’s earnings report. These are allegations under investigation, not findings of wrongdoing, but add a source of uncertainty for investors. Levi & Korsinsky investor investigation notice
Wall Street Analysts Forecast Growth
AXON has been the topic of a number of recent analyst reports. Zacks Research cut shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 3rd. Weiss Ratings restated a “hold (c-)” rating on shares of Axon Enterprise in a research report on Tuesday, November 3rd. Northland Securities set a $540.00 price objective on shares of Axon Enterprise in a research report on Friday, November 6th. Piper Sandler reaffirmed an “overweight” rating and set a $540.00 price objective (down from $561.00) on shares of Axon Enterprise in a research note on Friday, November 6th. Finally, Argus lifted their target price on Axon Enterprise from $460.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday, September 3rd. Thirteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and an average price target of $612.18.
Read Our Latest Research Report on AXON
Insider Buying and Selling at Axon Enterprise
In other news, insider Isaiah Fields sold 1,017 shares of the stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $480.45, for a total transaction of $488,617.65. Following the completion of the transaction, the insider directly owned 56,264 shares in the company, valued at $27,032,038.80. This represents a 1.78% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey Kunins sold 9,605 shares of the firm’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $626.70, for a total value of $6,019,453.50. Following the completion of the transaction, the insider owned 97,761 shares of the company’s stock, valued at $61,266,818.70. The trade was a 8.95% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 37,397 shares of company stock valued at $21,234,034. Corporate insiders own 4.20% of the company’s stock.
Axon Enterprise Company Profile
Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.
See Also
- Five stocks we like better than Axon Enterprise
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
